Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review

J Am Acad Dermatol. 2015 Aug;73(2):329-31. doi: 10.1016/j.jaad.2015.04.012.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Review
  • Systematic Review

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Etanercept
  • Female
  • Follow-Up Studies
  • Humans
  • Immunoglobulin G / administration & dosage*
  • Immunoglobulin G / adverse effects
  • Male
  • Patient Safety
  • Psoriasis / diagnosis*
  • Psoriasis / drug therapy*
  • Pulse Therapy, Drug
  • Randomized Controlled Trials as Topic
  • Receptors, Tumor Necrosis Factor / administration & dosage*
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Adalimumab
  • Etanercept